Isomorphic Labs closes $2.1bn funding round
Isomorphic Labs, the London based artificial intelligence specialist spun out of Google DeepMind, has secured $2.1bn billion dollars in a Series B funding round to accelerate its work on drug discovery. This capital injection marks a significant milestone for the drug design sector and highlights growing investor confidence in the application of generative AI within the life sciences and healthcare…